BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31948893)

  • 1. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
    Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function.
    George LK; Koshy SKG; Molnar MZ; Thomas F; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28765150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.
    Barutaut M; Fournier P; Peacock WF; Evaristi MF; Caubère C; Turkieh A; Desmoulin F; Eurlings LWM; van Wijk S; Rocca HB; Butler J; Koukoui F; Dambrin C; Mazeres S; Le Page S; Delmas C; Galinier M; Jung C; Smih F; Rouet P
    Int J Cardiol; 2020 Feb; 300():245-251. PubMed ID: 31806281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.
    Ferreira JP; Girerd N; Pellicori P; Duarte K; Girerd S; Pfeffer MA; McMurray JJ; Pitt B; Dickstein K; Jacobs L; Staessen JA; Butler J; Latini R; Masson S; Mebazaa A; Rocca HP; Delles C; Heymans S; Sattar N; Jukema JW; Cleland JG; Zannad F; Rossignol P;
    BMC Med; 2016 Nov; 14(1):181. PubMed ID: 27829460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
    McAlister FA; Ezekowitz J; Tarantini L; Squire I; Komajda M; Bayes-Genis A; Gotsman I; Whalley G; Earle N; Poppe KK; Doughty RN;
    Circ Heart Fail; 2012 May; 5(3):309-14. PubMed ID: 22441773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.
    Smith DH; Thorp ML; Gurwitz JH; McManus DD; Goldberg RJ; Allen LA; Hsu G; Sung SH; Magid DJ; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):333-42. PubMed ID: 23685625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.
    Lawson CA; Testani JM; Mamas M; Damman K; Jones PW; Teece L; Kadam UT
    Int J Cardiol; 2018 Sep; 267():120-127. PubMed ID: 29957251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
    Zamora E; Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Urrutia A; Domingo M; Bayes-Genis A
    Clin Chem; 2014 Mar; 60(3):481-9. PubMed ID: 24255081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning-Based Mortality Prediction in Chronic Kidney Disease among Heart Failure Patients: Insights and Outcomes from the Jordanian Heart Failure Registry.
    Izraiq M; Alawaisheh R; Ibdah R; Dabbas A; Ahmed YB; Mughrabi Sabbagh AL; Zuraik A; Ababneh M; Toubasi AA; Al-Bkoor B; Abu-Hantash H
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793014
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic comparison between creatinine-based glomerular filtration rate formulas for the prediction of 10-year outcome in patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention.
    Ballo P; Chechi T; Spaziani G; Fibbi V; Conti D; Ferro G; Nigrelli S; Dattolo P; Fazi A; Santoro GM; Zuppiroli A; Pizzarelli F
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):689-702. PubMed ID: 29064262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function in heart failure: a disparity between estimating function and predicting mortality risk.
    Plischke M; Neuhold S; Kohl M; Heinze G; Sunder-Plassmann G; Pacher R; Hülsmann M
    Eur J Heart Fail; 2013 Jul; 15(7):763-70. PubMed ID: 23429976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for one-year mortality in patients with acute heart failure with and without chronic kidney disease: differential impact of beta-blocker and diuretic treatments.
    Matsushita K; Minamishima T; Sakata K; Satoh T; Yoshino H
    Hypertens Res; 2019 Jul; 42(7):1011-1018. PubMed ID: 30659283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease.
    Santer L; López B; Ravassa S; Baer C; Riedel I; Chatterjee S; Moreno MU; González A; Querejeta R; Pinet F; Thum T; Díez J
    Hypertension; 2019 Apr; 73(4):820-828. PubMed ID: 30686085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HF.
    Damman K; Masson S; Lucci D; Gorini M; Urso R; Maggioni AP; Tavazzi L; Tarantini L; Tognoni G; Voors A; Latini R
    J Card Fail; 2017 Jan; 23(1):2-9. PubMed ID: 27638233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.
    Patel RB; Fonarow GC; Greene SJ; Zhang S; Alhanti B; DeVore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; McDermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Vaduganathan M
    J Am Coll Cardiol; 2021 Jul; 78(4):330-343. PubMed ID: 33989713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.